GRAPPA 2025 Collaborative Research Network Meeting: Difficult-to-Treat Psoriatic Arthritis and Future Strategies for Curing Psoriasis.
Publication Title
The Journal of rheumatology
Document Type
Article
Publication Date
5-15-2026
Keywords
washington; swedish; seattle
Abstract
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Collaborative Research Network meeting in Bogotá, Colombia, experts in dermatology and rheumatology presented complementary perspectives on the future of psoriatic disease management. Dr. Andrew Blauvelt introduced innovative approaches to achieving long-term remission or a cure for psoriasis, focusing on early intervention and "knockout" therapies with high-dose interleukin 23 inhibitors. Dr. Philip Mease presented evolving concepts in difficult-to-treat and complex-to-manage psoriatic arthritis, emphasizing the need for formal definitions and the growing role of dual therapy strategies. This session reflected a shift toward a more personalized, proactive, and multidisciplinary strategy to address unmet needs in psoriatic disease.
Area of Special Interest
Orthopedics & Sports Medicine
Specialty/Research Institute
Rheumatology
Specialty/Research Institute
Orthopedics
DOI
10.3899/jrheum.2026-0369
